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Abstract
Nanoscale cerium dioxide (nanoceria) has industrial applications, capitalizing on its catalytic,
abrasive, and energy storage properties. It auto-catalytically cycles between Ce3+ and Ce4+,
giving it pro-and anti-oxidative properties. The latter mediates beneficial effects in models of
diseases that have oxidative stress/inflammation components. Engineered nanoparticles
become coated after body fluid exposure, creating a corona, which can greatly influence their
fate and effects. Very little has been reported about nanoceria surface changes and biological
effects after pulmonary or gastrointestinal fluid exposure. The study objective was to address
the hypothesis that simulated biological fluid (SBF) exposure changes nanoceria’s surface
properties and biological activity. This was investigated by measuring the physicochemical
properties of nanoceria with a citric acid coating (size; morphology; crystal structure; surface
elemental composition, charge, and functional groups; and weight) before and after exposure to
simulated lung, gastric, and intestinal fluids. SBF-exposed nanoceria biological effect was
assessed as A549 or Caco-2 cell resazurin metabolism and mitochondrial oxygen consumption
rate. SBF exposure resulted in loss or overcoating of nanoceria’s surface citrate, greater
nanoceria agglomeration, deposition of some SBF components on nanoceria’s surface, and
small changes in its zeta potential. The engineered nanoceria and SBF-exposed nanoceria
produced no statistically significant changes in cell viability or cellular oxygen consumption
rates.

Keywords: A549 Cells; body fluids; Caco-2 cells; cellular respiration; cerium; engineered
nanoparticles; hydrodynamic diameter; microscopy, electron, transmission; nanoceria;
nanoparticle corona; spectroscopy, Fourier transform infrared; thermogravimetric analysis; X-ray
diffraction
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Abbreviations:
DLS: Dynamic light scattering
EDS: Energy-dispersive X-ray spectroscopy
ENP: Engineered nanoparticle
FaSSGF: Fasted-state simulated gastric fluid
FeSSGF: Fed-state simulated gastric fluid
FaSSIF: Fasted-state simulated intestinal fluid
FeSSIF: Fed-state simulated intestinal fluid
FTIR: Fourier-transform infrared spectroscopy
GIF: Gastrointestinal fluid
OCR: Oxygen consumption rate
SBF: Simulated body fluid (an inclusive term for FaSSGF, FeSSGF, FaSSIF, FeSSIF, and SLF)
SLF: Simulated lung fluid
TEM: Transmission electron microscopy
TGA: Thermogravimetric analysis
XRD: Powder X-ray diffraction
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Introduction
Engineered nanoparticles (ENPs) are typically coated to enhance their stability (deter
agglomeration) and/or target their distribution. Once they enter the biological milieu, the coating
may be removed, altered by body fluids, or overcoated by body fluid components, creating a
corona. The chemistry and morphology of the nanoparticle surface, what cells “see”, can greatly
influence its fate and effects [1, 2]. For many nanoparticles the influence of biological fluids to
remove, alter, or overcoat the applied coatings has not been well characterized.

Studies of Ag nanoparticles exposed to oral and gastrointestinal fluids (GIFs) have been
reported [3-6]. Reports have described the effect of GIFs on SiO2 and ZnO nanoparticles and
resultant particle effects on Caco-2 cells [7-9] and the effect of GIFs on CuO nanoparticles and
small intestine cell response [10]. GIF exposure caused agglomeration/deagglomeration of Ag,
SiO2, Al0, and γ-Al2O3 nanoparticles [3-5, 8, 11]. With the exception of changes in the zeta
potential [10] or surface elemental analysis [11] that were not assessed for biological effect,
nanoparticle surface properties were not reported in these studies.

Exposure of ENPs to GIFs or their components can change their surface properties. The
surface charge of nanotitania and nanosilica became more electronegative after pancreatin and
bile extract exposure [12]. Fourier-transform infrared spectroscopy (FTIR) revealed protein and
bile salt adsorption on nanotitania and nanosilica surfaces. Nanotitania cell toxicity was
attributed to the bile salt adsorption. Incubation of Fe3O4 nanoparticles with bread in simulated
salivary and GIFs resulted in size, surface charge, and protein corona changes, resulting in
morphological changes (an increase in the number of apical membrane vesicles) and greater
Caco-2 uptake of exposed NPs [13]. Exposure of CdSecore/ZnSshell quantum dots to GIFs altered
the polyethylene glycol coating, revealed by FTIR. The effect on biological response was not
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reported [14]. Silicon carbide and TiC nanoparticle exposure to human reconstituted gastric fluid
resulted in surface carbon and nitrogen adsorption [15]. The surface and pore structure of
mesoporous SiO2 particles was altered by exposure to salivary and GIF. The effect on biological
response was not reported [16].

Much less work has been reported with simulated lung fluids (SLFs). Nanoscale ZnO, CuO,
Fe3O4, TiO2, and CeO2 aggregated in SLFs, including pulmonary artificial lysosomal fluid and
Gamble solution. Nanoscale CeO2 dissolution was 5.5% after two h in a gastric fluid, < 0.2%
after two h in an in vitro gastric and four h in an in vitro intestinal fluid, and none after 24 h in
artificial lysosomal fluid or Gamble’s solution [17]. Exposure of nanoscale CeO2, silica-coated
CeO2, BaSO4, and ZnO to rat concentrated bronchoalveolar lavage fluid resulted in
agglomerated particles with increased conductance, a negative surface charge (-19 to -15 mV in
water), and a corona containing nine identified proteins [18]. The effect on biological response
of body-fluid exposed NPs in these two studies was not reported.

Nanoceria (nanoscale cerium dioxide, ceria, CeO2) is auto-catalytically redox active, cycling
between Ce3+ and Ce4+. It has a high oxygen storage capacity. Oxygen vacancies in its cubic
fluorite structure allow it to easily accept and donate oxygen without significantly altering its
geometry. These properties are described in detail in [19]. It displays superoxide dismutase and
catalase mimetic activity. It has commercial applications and therapeutic potential for conditions
with an oxidative stress/inflammation component [20]. Nanoceria has been shown to have
beneficial effects in animal models of cardiomyopathy [21], ventricular hypertrophy [22], cardiac
toxicity [23], ovarian cancer [24], pancreatic cancer [25], ischemic stroke [26], retinal
degeneration [27], sepsis [28], and hypobaric hypoxia [29]. It has been shown to promote
wound healing [30] and improve microvascular function in a model of hypertension [31]. Studies

5

have shown that it can improve the reproductive system of aged and diabetic male rats [32, 33]
and provide protection against radiation-induced gastric, lung, salivary, dermatologic, and bone
marrow toxicity [34-37], and endometriosis [38]. It has been shown beneficial in rodent models
of multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer’s disease, Parkinson’s disease,
diabetic neuropathy, traumatic brain injury, and intracerebral hemorrhage [39-46]. It has been
shown to reduce adverse brain effects of diesel exhaust exposure [47], ethanol- and stressinduced gastric lesions [48, 49], chemical-induced hepatic and pancreatic toxicity [50, 51], and
ischemia-induced hepatic reperfusion injury [52]. It reduced weight gain [53] and obesity-related
inflammatory effects [54]. However, there is concern about potential adverse effects from
nanoceria environmental exposure (e.g., from its use as a diesel fuel additive [55]) and
occupational exposure [56]. Adverse effects from in vivo pulmonary exposure have been
demonstrated [57-61].

Cell response to ENPs is dependent on particle physicochemical properties such as size,
surface charge, and morphology. Consequently, alterations in these characteristics can lead to
favorable or adverse outcomes. For example, application of a surface coating, such as citrate, is
routinely conducted to provide biocompatibility and deter agglomeration by providing a charged
surface [62, 63]. Proteins can coat ENPs to form a corona [1] and be subsequently displaced by
other proteins or removed. For example, nanoceria reversibly adsorbs albumin. Albumin
interacts with nanoceria in blood due to its prevalence but would be replaced over time by
fibrinogen that has a higher affinity [64, 65]. These alterations can change the particle surface
charge [66]. Aside from two studies ([17] and [18]) we are not aware of reports of the effect of
lung or GIFs on nanoceria. As noted, in vivo interactions and resulting protein corona formation
are not well understood and will be a focus in advancing our knowledge of nanoceria’s potential
biomedical applications [20].
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This study investigated the effects of human SLF and GIFs on nanoceria surface properties and
the effect of the simulated body fluid (SBF)-exposed nanoceria on cell viability and oxygen
consumption, to test the hypothesis that exposure to SBFs results in surface changes that affect
cell response. It was anticipated that exposure to these SBFs would change the surface charge
and coating of citrate-coated nanoceria, which might change cell response to the altered
nanoceria. Nanoceria was synthesized by a hydrothermal method, citrate coated, purified by
centrifugation and dialysis against water, and extensively characterized to determine its
physicochemical identity. It was exposed to simulated lung, gastric, and intestinal fluids, and
then again extensively characterized. The SBF-exposed nanoceria was isolated and its effect
on the viability and oxygen consumption rate of relevant cells assessed (A549 for SLF-exposed
nanoceria and Caco-2 for simulated gastric- and intestinal fluid-exposed nanoceria) to
determine its biological identity.
Materials and Methods
Materials
The chemicals, their sources, and purity were: acetic acid (glacial), Fisher Scientific, 100%;
calcium chloride dihydrate, Fisher Scientific, USP/FCC; cerium nitrate hexahydrate, Fluka
Analytical, ≥ 99%; citric acid monohydrate, Fisher Chemical, 100%; citric acid trisodium salt
dihydrate, VWR, ≥ 99%; disodium hydrogen phosphate, Fisher Scientific, ACS grade; lecithin
from egg, MP Biomedicals, ≥ 96%; hydrochloric acid, Fisher Reagent, 37% ACS grade;
lipopolysaccharide E. Coli 0127:B8 (LPS), Sigma, ≥ 500,000 EU/mg; magnesium chloride,
Strem Chemicals, 97.5%; maleic acid, TCI, 99%; pepsin, MP Biomedicals; potassium chloride,
Sigma, ~ 99%; resazurin, sodium salt, Sigma, ~ 80% dye content; sodium acetate, Sigma
Aldrich, ≥ 99%; sodium chloride, Sigma, ≥ 99%; sodium hydrogen carbonate, EM, 98.8%;
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sodium hydroxide, Fisher Chemical, 98.8%; sodium oleate, TCI, > 97%; sodium sulfate, Sigma
Aldrich, ≥ 99%; sodium taurocholate hydrate, Alfa Aesar, 96%; and Triton-X 100 (Biorad).
Oligomycin, (4 (trifluoromethoxy) phenyl) carbonohydrazonoyl dicyanide (FCCP) and rotenone
were obtained from Biomol. Antimycin A was obtained from Sigma. Regenerated cellulose
dialysis tubing that allows up to 12,000 to 14,000 MW passage was from Ward's Science, West
Henrietta, NY. Two % cow milk was used. A549 cells were obtained from Dr. Jill Kolesar,
College of Pharmacy, University of Kentucky. Caco-2 cells were obtained from Dr. Kyungbo
Kim, College of Pharmacy, University of Kentucky. The identity of both cell lines was verified by

the University of Arizona Genetics Core. MEM and DMEM (Gibco), phosphate-free DMEM
(Gibco), and low endotoxin FBS (Gibco) were used.

Methods
Nanoceria synthesis
Nanoceria was synthesized following a hydrothermal method [67]. The goal was to synthesize
particles that were large enough to isolate and purify by centrifugation and washing. An
aqueous solution containing 35 mL of 6 M sodium hydroxide and 5 mL of 0.05 M cerium nitrate
hexahydrate was combined and stirred for 30 min at 350 rpm. The contents were then
transferred to an autoclave and heated for 24 h at 180 °C, followed by cooling at room
temperature for 24 h. The resulting suspension containing cerium oxide and sodium nitrate was
centrifuged at 4200 rpm for 15 min, then washed and repeated three times. The cerium oxide
pellet was dispersed and dialyzed against 10 volumes (relative to the nanoceria dispersion) of
deionized water for 72 h at 350 rpm (changed every 24 h) to remove excess salt and cerium
ions. The nanoceria suspension was centrifuged at 4200 rpm for 15 min, washed and repeated
three times, and then dried overnight at 80 °C.
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Citrate layer application
Approximately 0.3 g of nanoceria was added to a beaker containing 200 mL of 0.05 M citric acid
adjusted to pH 4.5, stirred for 24 h, then centrifuged at 4200 rpm for 15 min. The supernatant
was decanted, the citrate-coated particles washed with deionized water three times, then dried
at 80 °C overnight. The citrate-coated nanoceria was characterized as described below.

Characterization of non-coated, citrate-coated, and SBF-exposed nanoceria
Powder X-ray diffraction (XRD; Bruker D8 Advance A25 with Cu source) was performed on a 10
mg sample to determine its crystal structure. The crystal planes of the peaks were assigned as
described [68]. Selected area electron diffraction was also conducted. Nanoceria was coated on
copper grids (300 mesh, lacey carbon #01895, from Ted Pella, Redding, CA) by brief immersion
in the nanoceria dispersion to determine primary particle morphology, size, and surface
elemental composition. This was conducted by transmission electron microscopy (TEM) and
scanning transmission electron microscopy (STEM) using a Thermo Scientific Talos F200X
operated at 200keV and equipped with a 4 silicon drift detector (SDD)-based energy dispersive
x-ray spectroscopy (EDS) system for chemical composition analysis and surface elemental
distribution mapping. The TEM images are recorded on a Ceta CCD camera. The polygon tool
of ImageJ was used to outline 231 particles from five TEM images of citrate-coated nanoceria.
Geometric comparison of the square root of area vs. Feret diameter demonstrated that the
particles were near cubic. To determine hydrodynamic diameter by dynamic light scattering
(DLS) and surface charge as zeta potential, one mg of the dried solid was dispersed in 2 mL of
deionized water, facilitated by bath sonication for five min, in a cuvette. A 90Plus Nanoparticle
Size Distribution Analyzer (Brookhaven Instruments Corporation, Holtsville, NY) and LitesizerTM
500 Particle Analyzer (Anton Paar, Ashland, VA), respectively, were used. Hydrodynamic
diameter was determined from five consecutive five-minute determinations. The zeta potential
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was determined multiple times from pH 1 to 12. Fourier transform infrared spectroscopy (FTIR)
was conducted on the dried nanoceria (Nicolet 6700) to identify surface functional groups by
their vibration-induced peaks in the infrared spectrum. Three scans were obtained for each
material. FTIR peak assignments were: –C-H, -CH2, and –CH3 1000 to 1500; C-O- ~ 1100; –CH 1350 to 1480; -COOH ~ 1380 and 1540; - N-O ~ 1650; C=O 1670 to 1820; and -OH between
3000 and 3600 cm-1. Thermogravimetric analysis (TGA; Perkin Elmer TGA7) was performed on
10 to 15 mg samples to determine the extent of citrate and SBF-deposited surface coatings.
Nitrogen was used as an inert gas purge. The temperature was held at 125 ˚C for 30 minutes to
release adsorbed water, then raised 10 ˚C/min above 125 ˚C. Increasing the temperature
causes neighboring surface hydroxyls to lose water and pyrolyzes organic compounds from the
nanoceria surfaces.

SBF preparation
Five SBFs; lung fluid (Gamble’s solution, which represents the interstitial fluid deep within the
lung, as the SLF), fasted-state simulated gastric fluid (FaSSGF), fed-state simulated middle
gastric fluid (FeSSGF), fasted-state simulated intestinal fluid (FaSSIF), and fed-state simulated
middle intestinal fluid (FeSSIF) were prepared as described, with modifications [69-71].
Preparation of the FeSSIF deviated from the [69] formula by exclusion of glyceryl monocholate
and from the [71] formula by exclusion of glyceryl monooleate because they prevented isolation
of washed, dried nanoceria amenable to the characterization described above. The glyceryl salt
and sodium oleate were excluded from the Caco-2 cell FeSSIF medium because their inclusion
killed the cells. The SBFs were sterilized by 0.2 µm filtration.

SBF nanoceria exposure
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Nanoceria (70 mg) and SBF (15 ml) in a 25 ml centrifuge tube were agitated on an orbital
shaker (INNOVA 4000, New Brunswick Scientific, Edison, NJ) at 250 rpm and 37 °C. Exposure
to SLF was three h, gastric fluids two h, and intestinal fluids six h, each conducted in three
independent replications. After exposure, the dispersions were centrifuged at 3500 rpm for 10
min, washed with deionized water three times, dried overnight at 80 °C, and characterized as
described above.

Assessment of nanoceria effect on cell metabolism before and after SBF exposure
To quantify cell metabolism, A549 cells were grown in 24 well plates in DMEM with 10% FBS.
Caco-2 cells were grown in 24 well plates in Eagle’s MEM with 20% FBS. The resazurin (AKA
alamarBlue®) assay was used to assess viability of A549 cells to citrate-coated nanoceria that
had not been SLF exposed as well as SLF-exposed nanoceria, and Caco-2 cells to nanoceria
before and after simulated gastric and intestinal fluid exposure. The cells were grown to near
confluence then washed three times (with phosphate-free DMEM) to remove cell culture growth
medium. They were then exposed to nanoceria (0, 1, 5, 20, and 100 µg/cm2 cell culture dish
area, equivalent to 0, 3.8, 19, 76, and 380 µg/ml), that had been SBF-exposed, dispersed by
sonication in the same SBF to maintain the nanoceria surface coating (corona) acquired during
SBF exposure. Exposure duration was three, two, or six h for lung-, gastric fluid-, and intestinal
fluid-exposed nanoceria, respectively. They were also exposed to citrate-coated nanoceria that
had not been SBF exposed, introduced as an iso-osmotic dispersion in citric acid at pH 7.4,
dispersed in phosphate-free DMEM. The cells were then washed three times (with PBS),
exposed to 18.75 (for A549 cells) or 25 µg/ml (for Caco-2 cells) resazurin in MEM containing
10% FBS. Absorbance readings were obtained after one and two h. Addition of 100 µg/ml
citrate-coated nanoceria to resorufin (the resazurin reduction product) did not alter resorufin
fluorescence, compared to citric acid addition, suggesting nanoceria does not interfere with the
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resazurin assay. A549 cells tolerated SLF exposure. Caco-2 cells did not tolerate exposure to
100% of the simulated gastric or intestinal fluids. It was necessary to include some cell culture
medium with these four SBFs to avoid very low viability. Gastric and intestinal SBFs were mixed
with DMEM that was phosphate free (to avoid nanoceria phosphate complexation) and in the
absence of FBS (to avoid nanoceria protein adherence [72]). Due to the low pH (1.6) of
FaSSGF we were unable to assess the effect of FaSSGF-exposed nanoceria on Caco-2 cell
viability in a medium containing mostly FaSSGF. Caco-2 cell viability was < 5% in 100%
FaSSGF and mixtures containing equal volumes of FaSSGF and cell culture medium compared
to phosphate- & FBS-free DMEM. Caco-2 cell viability averaged ~ 10 and 95% in the presence
of 90% FeSSGF:10% phosphate-FBS-free DMEM and 75% FeSSGF:25% phosphate-FBS-free
DMEM, respectively, compared to phosphate-FBS-free DMEM. Caco-2 cell viability averaged
109 and 97% in the presence of 90% FaSSIF or FeSSIF, respectively:10% phosphate-FBS-free
DMEM, compared to phosphate-FBS-free DMEM. Based on these results, during the viability
assay Caco-2 cells were exposed to 75% of FeSSGF and 25% phosphate- & FBS-free DMEM,
or 90% of the simulated intestinal fluids and 10% phosphate- & FBS-free DMEM. Viability
assays were conducted in three independent experiments, each containing two wells with each
nanoceria concentration. LPS and Triton-X 100 were tested as positive controls. Two-hour
exposure to 0.1, 0.3, or 1 µg/ml LPS reduced Caco-2 cell viability 3, 13, and 11%, respectively.
Six-hour exposure to these concentrations reduced Caco-2 cell viability 7, 13, and 13%,
respectively. We (unpublished results with RAW 264.7 cells) and others have found LPS effects
to be quite concentration independent [73]. Two-hour exposure to 0.001, 0.003, 0.01, 0.03, 0.1,
0.3, 1, 3, or 10% Triton-X 100 reduced Caco-2 cell viability to ~ 0 for all but the two lowest
concentrations (~ 90% viability). After six-hour exposure to 0.001 and 0.003% Triton-X 100,
Caco-2 cell viability was ~ 80 and 50%, respectively. These results demonstrate resazurin
assay sensitivity to reduced cell metabolism.
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Assessment of nanoceria effect on cellular respiration before and after SBF exposure
Cellular oxygen consumption rates (OCRs) of A549 and Caco-2 cells in response to uncoated,
citrate-coated, and SBF-exposed citrate-coated nanoceria were determined using a Seahorse
XFe96 Analyzer (Agilent). The standard Seahorse XF Cell Mito Stress Test protocol was
performed by measurement of OCRs after stepwise injection of 2.5 µM oligomycin, FCCP (0.5
µM for A549 cells and 0.25 µM for Caco-2 cells), and 1 µM rotenone and 10 µM Antimycin A
that generated multiple endpoints of cellular respiration. A549 cells (25,000/well) were exposed
for three h to DMEM with 10% FBS, phosphate-FBS-free DMEM, uncoated and citrate-coated
nanoceria in phosphate-FBS-free DMEM, SLF, and nanoceria in SLF that had been immediately
previously exposed to SLF for three h. Caco-2 cells (20,000/well) were exposed to the same
conditions for two h with FeSSGF replacing SLF and for six h with FaSSIF and FeSSIF
replacing SLF. Nanoceria was tested at 0, 1, 5, 20, and 100 µg/cm2 Seahorse plate well area,
equivalent to 0, 1.1, 5.7, 23, and 114 µg/ml. Each condition was tested in at least duplicate wells
in at least three replicate experiments.

Data and statistical analysis
Zeta potential results were fitted using a Carreau equation that models “plateau” areas at high
and low pH values and a logarithmic region between these two extremes, as we previously
employed [74].

The uncoated TGA nanoceria data were used as a control for water loss, and additional weight
losses from the coated samples were attributed to organic acids (acetic, citric, maleic, or
taurocholic acid) or casein (in the FeSSGF sample). The temperature of comparison was 500
°C. Material balances were calculated on the organic acid weight losses for an average
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nanoceria particle size (21.1 nm side length, 9393 nm3 volume). Lost organic coating weights
were converted to lost volumes using the densities of the specific organic acids, giving an
estimate of the nanoceria + coating volume and cubic diameter. These were compared to the
size of an individual organic acid to estimate whether the coating was much less than a
monolayer, ¼ to ½ a monolayer, a monolayer, or larger. The FeSSGF sample contained milk
proteins, of which 80% are caseins. Caseins are well-known colloidal particle adsorbents and
stabilizers [75, 76] and proteins are known to adsorb to nanoceria [74]. Κ-casein, an appropriate
model for milk proteins, is known to have a typical area of 40 nm2 when adsorbed on colloids
[75]. The average nanoceria particle had a surface area of 2646 nm2. If Κ-casein coverage was
a monolayer, the average nanoceria particle of 21.1 nm side length would have 66 Κ-casein
molecules attached to its surface. The weight of the adsorbed layer was then compared directly
to the weight of 66 Κ-casein molecules.

Resazurin assay absorbance in the absence of cells was subtracted from the absorbance from
cell metabolism, expressed as a percentage of the latter, and nanoceria concentration
dependence, compared to its absence, assessed for statistical significance by one-way ANOVA.
Cell viability was determined from the one h absorbance results (absorbance was linear from
zero to one to two h). Results are reported as mean ± S.D.

Oxygen consumption rate results were baselined to non-mitochondrial respiratory rates and
further normalized to the protein content in the respective well (determined by the BCA method).
The effect of phosphate-FBS-free DMEM on cell respiration was determined by comparing the
OCR to it and DMEM with 10% FBS. The effect of SBF on cell respiration was determined by
comparing cell response to the SBF and phosphate-FBS-free DMEM. The effect of uncoated
and citrate-coated nanoceria on basal and maximal OCR was determined as the response of
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cells exposed to nanoceria in phosphate-FBS-free DMEM/cells exposed to phosphate-FBS-free
DMEM. The effect of SBF exposed-nanoceria on cellular respiration was determined as the
response to SBF- exposed nanoceria in SBF/the SBF. The mean and standard deviation of the
experimental averages was calculated and subjected to one-way ANOVA to test for significant
differences between nanoceria and non-nanoceria-exposed cells.

Results
Uncoated and citrate-coated nanoceria characterization results
X-ray diffraction analysis and selected area electron diffraction of the uncoated and citratecoated nanoceria demonstrated its crystallinity and showed (111), (200), (220), and (311)
crystal planes. Figure 1 shows a representative XRD example for citrate-coated nanoceria and
the predominant crystal planes. Consistent results were obtained with selected area electron
diffraction (results not shown). The crystalline nature was similar to the reported spectrum for
cerium oxide (JCPDS Card #34_0394). The crystal structure of nanoceria is cubic fluorite [77].
STEM images of the uncoated and citrate-coated nanoceria as well as the nanoceria after SBF
exposure show it was cubic-shaped (Figure 2). Primary particle size (particles that cannot be
separated into smaller particles except by the application of ultrahigh energy) determined by
TEM is shown in Figure 3. Primary particle size distribution was best described as log normal.
The mean (S.D.) particle size was 21.1 (14.2) nm. Hydrodynamic diameter (the apparent size of
the solvated/dynamic hydrated particle in an aqueous medium) results determined by DLS, as
surface area, are displayed in Figure 4, and summarized in Table 1. The hydrodynamic
diameter of the uncoated and citrate-coated nanoceria was greater than the primary particle
diameter determined by TEM, suggesting particle agglomeration. Citrate coating produced an ~
10 mV greater absolute (negative) surface charge in the circumneutral pH range (Figure 5) and
a lower (ζinf) pH plateau zeta potential of ~ 30 mV (Table 2). This was associated with an ~
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25% reduction of the hydrodynamic diameter, attributed to the greater surface charge-induced
repulsion of the like-charged nanoceria particles. Successful surface coating with citric acid is
confirmed by FTIR (Figure 6) that shows an additional peak at (1380 cm-1) attributed to -COOsymmetric stretch and the 1% greater weight loss during TGA analysis (Figure 8). This
translates to on average 0.8 citrate molecules per nm2 on the surface of the primary particle that
translates to about ½ a monolayer (Table 3). This estimate assumes complete packing of the
adsorbate molecules on the surface. Random packing of adsorbates on surfaces often covers
only 50 to 54% of the available area [71].

Effect of simulated body fluid (SBF) exposure on citrate-coated nanoceria and effect of non- and
SBF-exposed nanoceria on cell viability
Exposure to SBFs for two to six h produced no observable surface degradation (Figure 2); but
SBF-dependent effects on hydrodynamic diameter (Figure 4 and Table 1), surface carbon
(Figure 2), zeta potential (Figure 5 and Table 2), FTIR (Figures 6 and 7), and TGA (Figure 8)
were seen. Citrate-coated and SBF-exposed nanoceria, up to 100 µg/cm2, did not significantly
affect A549 or Caco-2 cell viability (Figure 9). Details are described below.

Exposure to SLF resulted in a small increase in the mean hydrodynamic diameter (Figure 4 and
Table 1), loss of the FTIR peak at ~1380 cm-1 (Figure 6), and less weight loss during TGA
heating than the citrate-coated nanoceria (Figure 8). These results suggest some removal of
citrate from the nanoceria surface with possible replacement by a small amount of acetic acid
resulting in minimal coating thickness (Table 3). This was not accompanied by a less negative
surface charge (Figure 5) as might be anticipated with less citric acid on the surface, suggesting
some association of SLF components with the CeO2 surface. A549 cell metabolism was nonsignificantly increased by three h exposure to SLF-exposed nanoceria (Figure 9).
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Nanoceria exposure to FaSSGF increased its mean hydrodynamic diameter ~ 80% (Figure 4
and Table 1), associated with a less positive zeta potential at the FaSSGF pH (1.6) (Figure 5),
the loss of the FTIR peak at ~1380 cm-1 that is attributed to citric acid (Figure 6), and less weight
loss during TGA heating than the citrate-coated nanoceria (Figure 8). The possible loss of
citrate from the nanoceria surface may be due to FaSSGF’s very low pH (1.6).

Exposure of nanoceria to FeSSGF greatly increased its mean hydrodynamic diameter (Figure 4
and Table 1). There was no appreciable effect on the zeta potential other than an increase in
the isoelectric point (IEP) (Figure 5 and Table 2). The reduction of the 1380 cm-1 FTIR peak
attributed to citrate on the nanoceria surface (Figure 6), appearance of a peak at 1650 cm-1, and
large weight loss increase during heating (Figure 8) may be due to overcoating by FeSSGF
component(s), most likely from the milk. There is an additional FTIR peak at ~ 1750 cm-1
suggesting an organic component of milk was associated with the nanoceria surface. An FTIR
scan of dried milk is very similar to the FeSSGF-exposed nanoceria scan in the 1300-2000 cm-1
range, consistent with nanoceria surface coating by milk components (Figure 7). K-casein from
milk could form a coating that is one (if tightly packed) or two layers (if randomly or loosely
packed) thick (Table 3). The system containing protein does form a protein ‘corona’ around
nanoceria. Elemental scan shows FeSSGF-exposed nanoceria had the most carbon on its
surface among the SBF-exposed nanoceria. The increases in hydrodynamic diameter and IEP
can be attributed to adsorption of milk components on the nanoceria surface. Caco-2 cell
viability was not significantly affected by two h exposure to FeSSGF-exposed nanoceria in 75%
FeSSGF:25% phosphate- & FBS-free DMEM (Figure 9).
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Exposure of nanoceria to FaSSIF increased its mean hydrodynamic diameter ~ 25% (Figure 4
and Table 1). The zeta potential at the FaSSIF pH (6.5) became ~ 9 mV more negative (Figure
5), the 1380 cm-1 FTIR peak was greatly reduced (Figure 6), and weight loss during heating was
less than seen with citrate-coated nanoceria (Figure 8). The considerable loss of the 1380 cm-1
FTIR peak attributed to citrate on the nanoceria surface in the absence of increased weight loss
during heating and lack of additional FTIR peaks suggests removal of most of nanoceria’s
surface citrate without significant coating by FaSSIF’s organic components (Table 3). FaSSIFexposed nanoceria in 90% FaSSIF:10% phosphate-FBS-free DMEM had little effect on Caco-2
cell viability (Figure 9).

Nanoceria exposure to FeSSIF increased its mean hydrodynamic diameter ~ 155% (Figure 4
and Table 1). The zeta potential at the FeSSIF pH (5.8) became less negative (Figure 5), the
1380 cm-1 FTIR peak was greatly reduced in the absence of any new peaks (Figure 6), and
there was a considerable increase of the weight loss during heating (Figure 8). The loss of the
1380 cm-1 FTIR peak and increased weight loss during heating suggests overcoating by some
FeSSIF component(s), perhaps maleic acid, that would produce a monolayer coat on the
nanoceria (Table 3). The lowest concentration (1 µg/cm2) of FeSSIF-exposed nanoceria in 90%
FeSSIF:10% phosphate-FBS-free DMEM non-significantly increased Caco-2 cell viability,
whereas higher concentrations had little effect (Figure 9).

Effect of nanoceria and simulated body fluid (SBF) exposed nanoceria on the oxygen
consumption rate
Basal and maximal A549 OCRs in phosphate-FBS-free DMEM were 102 ± 2% (mean ± S.D.)
and 102 ± 1% of respiration in DMEM with 10% FBS, respectively. Caco-2 basal and maximal
cell respiration after two h were 85 ± 7% and 95 ± 7%, and after six h 93 ± 3% and 97 ± 3% in
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phosphate-FBS-free DMEM compared to DMEM with 10% FBS. A549 basal and maximal cell
respiration in SLF were 91 ± 9% and 93 ± 10% compared to phosphate-FBS-free DMEM. Caco2 basal and maximal cell respiration in FeSSGF, FaSSIF, and FeSSIF were 94 ± 25% and 88 ±
36%, 82 ± 13% and 87 ± 6%, and 84 ± 15% and 67 ± 12% compared to phosphate-FBS-free
DMEM, respectively.
Figure 10 shows a representative trace for A549 and Caco-2 results, indicating that the cell
respiration analyses were performing correctly, and responsive to treatments (oligomycin,
FCCP, rotenone and antimycin A, and cell culture media). Figure 11 shows the effects of
uncoated, citrate-coated, and SBF-exposed nanoceria on cellular respiration. There were no
statistically significant differences between nanoceria treatments and the control (nanoceria
free) condition. The results suggest nanoceria, uncoated, coated, or SBF-exposed, does not
have a profound effect on A549 or Caco-2 cell respiration up to 100 µg/cm2 (114 µg/ml), a quite
high concentration.

Discussion:
To our knowledge this is the first study to investigate the corona formed on nanoceria after
exposure to GI fluids and the effects of lung and GI fluid corona on cell response.

The lack of change in nanoceria primary particle size or shape during its two to six h SBF
exposure was expected, given its slow solubility at acidic pH, and lack of significant solubility at
circumneutral pH [17, 78, 79] and prior studies cited in the introduction to Yokel et al, 2019 [79].

Although there are many reports of nanoceria zeta potential, few provide sufficient details, such
as pH and medium, to fully interpret the results. Even fewer determined the zeta potential as a
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function of pH, as conducted in this study. Two studies reported nanoceria from commercial
sources to have an IEP of ~ pH 7 in water [80, 81], very different from the IEPs of our citratecoated nanoceria. The surface properties of these commercial materials are unknown. We have
unpublished results that show nanoceria annealed at 300 °C for one h has an IEP of 7.

The increase in nanoceria’s absolute (negative) surface pH after exposure to SLF is probably
due to association of phosphate with the surface Ce. Cerium is known to form a complex with
phosphate [82]. Cerium phosphate is quite insoluble, with reported log
stability/formation/equilibrium constants for Ce3+ phosphate of 3.4 × 1018 [83] and 3.7 × 1023 [84]
and for Ce4+ phosphate of 2.9 × 1034 [85].

Some prior studies of A549 viability found no significant effect after four or more h nanoceria
exposure up to or beyond 100 µg/ml [86-90]. In contrast, a significant decrease after 24 h
exposure to 3.5 µg/ml nanoceria [91], ~ 90% viability three h after 33 µg/ml [92], 80 and 86%
viability six and 24 h after exposure to 195 µg/ml [93], 90 and 85% viability after 24 h exposure
to 100 and 1000 µg/ml [64], and a 10 to 20% viability reduction after 24 h exposure to 67 µg/ml
[94] were reported. In contrast to a reduction of viability, increased cell viability after 24 h
exposure to five to 40 µg/ml of 50 and 300 (but not 30) nm ceria was reported [95]. The lack of
decreased A549 viability in the present study after three h exposure to up to 100 µg/cm2 citratecoated nanoceria agrees with most prior reports. Exposure to SLF (Gamble’s solution) did not
significantly affect nanoceria toxicity. Similar to most studies with A549 cells, prior studies found
no effect on Caco-2 cell viability after 24 h exposure to up to 200 µg/ml nanoceria [89, 96].
Results of the present study with SBF-exposed nanoceria are similar, however they suggest
that exposure to > 100 µg/cm2 fed-state gastric or intestinal fluid might significantly reduce
Caco-2 cell viability. In contrast, Caco-2 cell metabolism was reduced when exposed to < 100
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µg/ml SBF-exposed silver NPs [4], 100 µg/ml FaSSIF-exposed silica NPs [8], < 100 µg/cm2
SBF-exposed silica or ZnO NPs [9], and 10 µg/ml SBF-exposed nanotitania [12]. Rat IEC-6 cell
metabolism was reduced when exposed to < 100 µg/ml CuO NPs [10].

Similar to the cell viability response of A549 and Caco-2 cells to coated and SBF-exposed
nanoceria, OCR was not significantly affected by uncoated, coated, or SBF-exposed nanoceria.
There are no prior reports of OCR response to nanoceria. A549 and undifferentiated Caco-2 cell
OCR were shown to be responsive to nanomaterial and chemical insult [97, 98].

The lack of considerable effect of nanoceria on resazurin metabolism and OCR may be partly
due to the physical incompatibility of nanoceria in the SBFs. Introduction of the citrate-coated
nanoceria (as an aqueous dispersion) as well as the nanoceria that had been exposed to SBFs
(that were dispersed in the SBFs), resulted in visually noticeable nanoceria precipitation on the
cells. This indicates the lack of stability of nanoceria in the SBFs, which would be expected to
reduce its potential for cell uptake or cell membrane effects. This may contribute to the low
biological effects of citrate-coated nanoceria (adverse or beneficial) before and after SBF
exposure.

Nanoceria has been shown to be taken up by A549 and Caco-2 cells. Nanoceria (9 nm) was
observed by TEM in A549 cell vesicular structures and cytoplasm within 10 min of exposure.
Using ICP-MS to study uptake kinetics revealed non-saturated, ~ linear cell association of ~
60% of the nanoceria after 30 min [56]. Four h after exposure TEM showed 8 and 20 nm ceria
close to the A549 cell surface and in aggregates in endocytotic vacuoles. Uptake was
concentration dependent (from 10, 50, and 200 µg/ml) for 24 h [87]. Confocal microscopy of
Caco-2 cells showed nanoceria particles in fully differentiated (grown for 14 days) Caco-2 cells
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after 24 h exposure to 3.125 and 31.25 mg/cm2 < 25 nm ceria [99], and in undifferentiated
Caco-2 cells, including the nucleus, after 24 h exposure to 100 µg/ml 70 nm ceria [96].

Nanoceria concentrations in the present study that did not produce significant effects on A549
cells (≥ 1 µg/cm2) are greater than the nanoceria concentration in ambient air attributed to use
of nanoceria in diesel fuel (0.5 ng/m3) [100]. The only published study we are aware of that
assessed occupational nanoceria exposure did not find cerium in air samples during chemical
mechanical planarization in semiconductor device fabrication [101]. A two-year study of
nanoceria inhalation (NM212, 40 nm, agglomerates three to 150 µm) was conducted in rats
exposed to 0.1, 0.3, 1, or 3 mg/m3, 6 h daily, 5 days weekly. This resulted in time- and dosedependent increased polymorphonuclear leukocytes in the bronchoalveolar lavage fluid
(indicating inflammation), granuloma formation and giant cells after 12 months exposure to 1
mg/m3, and moderate chronic inflammation after 24 month exposure to 3 mg/m3 [102]. An
aerosol containing 1 mg/m3 nanoceria would contain one µg in 1000 cm3. Rat minute ventilation
is ~ 30 ml(cm3)/min [103]. One µg/cm2 (the lowest A549 cell exposure of the present study)
would represent the nanoceria inhaled from 1 mg/m3 by a rat in ~ 0.5 h. The A549 results
suggest neither the citrate-coated or SLF-exposed nanoceria would be predicted to result in
adverse effects after acute exposure to the nanoceria concentrations studied in rats or likely to
be inhaled by humans during occupational exposure.

Conclusion
Nanoceria synthesis was confirmed by XRD and selected area electron diffraction results
(crystalline identity) and EDS results (cerium and oxygen). Citrate coating addition was
demonstrated by a decrease in hydrodynamic diameter, an increase in the absolute surface
charge, FT-IR appearance of a carboxylate-assignable peak, and a moderate increase in mass
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loss during TGA heating. Some of the citrate persisted on the nanoceria surface after SBF
exposure. Following FeSSGF exposure, hydrodynamic diameter and weight loss during heating
increased, suggesting addition of material to the nanoceria surface. Similar, but less profound,
changes were seen following FeSSIF exposure. Exposure to SLF, FaSSGF, and FaSSIF
resulted in subtle changes. Neither the citrate-coated or SBF-exposed nanoceria produced
significant cell toxicity, suggesting acute nanoceria exposure to concentrations less than
extraordinary would not be predicted to produce adverse pulmonary or gastrointestinal effects.
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Table 1. Nanoceria hydrodynamic size.
Nanoceria
sample
Uncoated
Citrate coated
SLF exposed
FaSSGF exposed
FeSSGF exposed
FaSSIF exposed
FeSSIF exposed

Bimodal size distribution
(% by nm range)
41% 150-180; 59% 415-540
45% 85-105; 59% 310-450
43% 135-170; 57% 430-575
50% 185-250; 50% 600-775
43% 270-445; 57% 2450-3000
51% 135-185; 49% 420-550
38% 185-285; 62% 870-1150
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Table 2. Model estimates of the isoelectric point (IEP) and upper (ζ0) and lower (ζinf) pH plateau
zeta potentials.

IEP (pH)

Uncoated
2.7

Citrate coated
2.7

SLF
exposed
2.6

FaSSGF
exposed
2.6

FeSSGF
exposed
3.5

FaSSIF
FeSSIF
exposed exposed
2.4
2.9

ζ0 (mV)

19.8

27.5

11.9

11.1

20.4

7.3

8.8

ζinf (mV)

-21.5

-31.1

-35.6

-34.8

-29.0

-39.8

-35.6
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Table 3. Estimated coating thickness of citrate and simulated body fluids on nanoceria.
Sample

Sorbed ligand

Diameter of
Adsorbate
Coating
sorbed
molecule
thickness
complex
diameter (nm)
(nm)
Uncoated
Control
21.1
Control
Control
a
FaSSIF exposed
Maleic acid
21.2
0.61
<< monolayer
SLF exposed a
Acetic acid
21.2
0.57
<< monolayer
FaSSGF exposed a Taurocholic acid
21.3
1.1
≈ ¼ monolayer
Citrate coated a
Citric acid
21.4
0.72
≈ ½ monolayer
a
FeSSIF exposed
Maleic acid
21.6
0.61
≈ 1 monolayer
FeSSGF exposed b K-casein
Not applicable
Not applicable
1 to 2 layers
a
estimated from the weight of the coating for the average nanoceria particle diameter.
b
estimated by assuming that Κ-casein adsorbed to the average nanoceria particle size and
comparing the adsorbed weight to a closely packed (one layer) or randomly packed (two layers)
structure.
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Figures:
Figure 1. X-ray powder diffraction of the as-synthesized citrate-coated nanoceria.
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Figure 2. STEM images of nanoceria before and after SBF exposure and surface cerium,
oxygen, and carbon elemental maps. Each of the images in a row are the same size. A 50 nm
scale bar is in the first column of the row.
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Figure 3: Primary particle size distribution. Open circles are results of the 231 sized particles.
Solid line is the log normal distribution model for best fit.
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Figure 4. Nanoceria hydrodynamic diameter, as surface area, before and after SBF exposure.
(a) Nanoceria before citrate coating and SBF exposure. (b) Citrate-coated nanoceria before
SBF exposure. Nanoceria after exposure to (c) SLF, (d) FaSSGF, (e) FeSSGF, (f) FaSSIF, and
(g) FeSSIF.

31

Figure 5. Nanoceria surface charge (zeta potential) before and after citrate coating, and after
exposure to each SBF.
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Figure 6. Fourier transform infrared spectroscopy of the nanoceria before and after citrate
coating and after exposure to each SBF. Vertical dashed lines indicate –OH at 3400, N-O at
1650, and –COOH at 1380 cm-1.
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Figure 7. Fourier transform infrared spectroscopy of dried milk and nanoceria after FeSSGF
exposure. Vertical dashed lines indicate –OH at 3300, N-O at 1650, and –COOH at 1380 cm-1.
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Figure 8. Thermogravimetric analysis of nanoceria before and after citrate coating, and after
exposure to each SBF.
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Figure 9. Cell viability after exposure to nanoceria that had not or had been SBF exposed. The
standard deviation of the 100 µg/cm2 results in the lower left panel “Caco-2 cell response to
FaSSIF-exposed nanoceria” is 0.
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Figure 10. A549 and Caco-2 cell oxygen consumption rate response to selected media and
SBF-exposed nanoceria. Upper panel: A549 cell OCR response to selected media and 100
µg/cm2 SLF-exposed nanoceria. Lower panel: Caco-2 cell OCR response to selected media and
100 µg/cm2 FeSSIF-exposed nanoceria.
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Figure 11. A549 and Caco-2 cell basal and maximal oxygen consumption rate responses to
uncoated, citrate-coated, and SBF-exposed nanoceria.
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